The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt

Lancet

Volumn 355, Issue 9207, 2000, Pages 887-891

  Frank, Christina ^a   Mohamed, Mostafa K ^b   Strickland, G Thomas ^a   Lavanchy, Daniel ^c   Arthur, Ray R ^c   Magder, Laurence S ^a   El Khoby, Taha ^d   Abdel Wahab, Yehia ^d   Aly Ohn, El Said ^d   Anwar, Wagida ^d   Sallam, Ismail ^d  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b AIN SHAMS UNIVERSITY   (Egypt)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d MINISTRY OF HEALTH   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMONY TARTRATE; ANTISCHISTOSOMAL AGENT; HEPATITIS C ANTIBODY; METRIFONATE; NIRIDAZOLE; PRAZIQUANTEL; STIBOCAPTATE; STIBOPHEN;

ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; EGYPT; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; POPULATION EXPOSURE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; RISK FACTOR; SCHISTOSOMIASIS; SCHOOL CHILD; SEPTICEMIA; SEROPREVALENCE; VIRUS TRANSMISSION;

EID: 0034635771     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)06527-7     Document Type: Article

References (26)

1. Arthur R.R., Hassan N.F., Abdallah M.Y.et al. Hepatitis C antibody prevalence in blood banks in different governorates in Egypt. Trans R Soc Trop Med Hyg. 91:1997;121-124.
2. Mohamed M.K., Rakha M., Sheir S. Study of the risk factors for viral hepatitis C infection among Egyptians applying for work abroad. Egypt Publ Hlth Ass. 71:1996;113-147.
3. El-Sayed N.M., Gomatos P.J.et al. Seroprevalence survey of Egyptian tourism workers for hepatitis B virus, hepatitis C virus, HIV and Treponema pallidium infections. association of hepatitis C virus infections with specific regions of Egypt Am J Trop Med Hyg. 55:1996;179-184.
4. Abdel-Wahab M.F., Zakaria S., Kamel M.et al. High seroprevalence of hepatitis C infection among risk groups in Egypt. Am J Trop Med Hyg. 51:1994;563-567.
5. Darwish M.A., Faris E., Clemens J.D. High seroprevalence of hepatitis A, B, C and E viruses in residents in an Egyptian village in the Nile delta. a pilot study Am J Trop Med Hyg. 54:1996;554-558.
6. Mohamed M.K., Rakhaa M., Sheir S., Saber M. Viral hepatitis C infection among Egyptians. the magnitude of the problem: epidemiological and laboratory approach Egypt Publ Hlth Ass. 71:1996;79-111.
7. El Gohary A., Hassan A., Nooman Z.et al. High prevalence of hepatitis C virus among urban and rural population groups in Egypt. Acta Trop. 59:1995;155-161.
8. Dusheiko G., Schmilovitz-Weiss H., Brown D.et al. Hepatitis C virus genotypes. an investigation of type-specific differences in geographic origin and disease Hepatology. 19:1994;13-18.
9. McOmish F., Yap P.L., Dow B.C.et al. Geographical distribution of hepatitis C virus genotypes in blood donors. an international collaborative survey Clin Microbiol. 32:1994;884-892.
10. Mellor J., Holmes E.C., Jarvis L.M. Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions. implications for virus classification Gen Virol. 76:1995;2493-2507.
11. Quinti I., el-Salman D., Monier M.K., et al H.C.V. infection in Egyptians with acute hepatitis. Dig Dis Sci. 42:1997;2017-2023.
12. Darwish M.A., Raouf T.A., Rushdy P.et al. Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors. Am J Trop Med Hyg. 49:1993;440-447.
13. Farghaly A.G., Barakat R.M. Prevalence, impact and risk factors of hepatitis C infection. Egypt Publ Hlth Ass. 68:1993;63-79.
14. Quinti I., Renganathan E., El Ghazzawi E.et al. Seroprevalence of HIV and HCV infections in Alexandria, Egypt. Zbl Bakt. 283:1995;239-244.
15. El-Sayed H.F., Abaza S.M., Mehanna S. The prevalence of hepatitis B and C infections among immigrants to a newly reclaimed area endemic for Schistosoma mansoni in Sinai, Egypt. Acta Trop. 68:1997;229-237.
16. Hyams K.C., Mansour M.M., Massoud A., Dunn M.A. Parenteral antischistosomal therapy. a risk factor for hepatitis B infection J Med Virol. 23:1987;109-114.
17. Madwar M.A., El Tahawy M., Strickland G.T. The relationship between uncomplicated schistosomiasis and hepatitis B infection. Trans R Soc Trop Med Hyg. 83:1989;233-236.
18. Deelder A.M., Miller R.L., de Jonge N., Krijger F.W. Detection of schistosome antigen in mummies. Lancet. 335:1990;724-725.
19. Davis A. Antischistosomial drugs and clinical practice. Jordan P., Webbe G., Sturrick R.F. Human schistosomiasis. 1993;367 Centre for Agriculture and Biosciences International Press, Oxon.
20. Maegraith B.G. Treatment of bilharziasis in Egypt, UAR. 1964;WHO, Geneva.
21. Abdallah A. Resumé of some pilot control projects carried out in Egypt in the past 20 years. 1972;WHO, Geneva. (SCHISTO/WP/72.41).
22. Ghaffar Y.A., Fattah S.A., Kamel M., Badr R.M., Mahomed F.F., Strickland G.T. The impact of endemic schistosomiasis on acute viral hepatitis. Am J Trop Hyg. 45:1991;743-750.
23. The control of schistosomiasis: second report of the WHO expert committee. 1993;WHO, Geneva. (WHO Technical Report Series 830).
24. Statistical year book 1952-1992. 1993;Central Agency for Public Mobilisation and Statistics, Cairo.
25. El-Khoby T., Galal N., Fenwick A.et al. The epidemiology of chistosomiasis in Egypt: summary findings in nine governorates. Am J Trop Med Hyg. 2000;. (in press).
26. Sherif M.M., Abou-Aita B.A., Abou-Elew M.H.et al. Hepatitis B virus infection in upper and lower Egypt. J Med Virol. 15:1985;129-135.